Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Conestoga Mid Cap Composite. This analysis is provided for institutional research purposes only and is not investment advice.
"Conestoga's Small Cap Growth strategy returned 4.76% in 2Q25, underperforming the 11.97% benchmark return as unprofitable, high-beta stocks led the market rally following tariff policy relief. The portfolio's quality-focused approach faced headwinds, but management remains confident given small caps' attractive valuations and accelerating earnings growth after years of contraction."
Conestoga's Small Cap Growth Composite returned 4.76% net in 2Q25, underperforming the Russell 2000 Growth Index's 11.97% return. The quarter was marked by extreme volatility driven by tariff policy announcements, with markets initially declining 11% before rallying 25% from April lows. The portfolio's emphasis on profitable, high-quality companies proved challenging during a period when unprofitable stocks rose 13.1% versus 6.8% for profitable peers. Stock selection was negative across seven of nine sectors, with Technology, Industrials, and Health Care facing the largest headwinds. Key detractors included Descartes Systems and Simulations Plus due to tariff concerns, while Construction Partners benefited from robust infrastructure demand. The strategy exited underperforming positions including Neogen Corp and JBT Marel while adding Bright Horizons. Despite near-term headwinds from quality factor underperformance, management remains confident in their conservative growth approach given small caps' attractive valuations relative to large caps and accelerating earnings growth following years of contraction.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
Conestoga runs moderately diversified portfolios with holdings ranging from 25 to 60. The manager shows strong belief in individual high-quality names like FICO, AXON, and EXPO, but balances this with wider diversification across multiple strategies.
Growth Outlook
The manager remains constructive over the medium term, citing historically low small-cap valuations and re-emerging earnings growth. However, they express caution regarding short-term macro headwinds such as tariffs and central bank policy.
Risk Appetite
While maintaining fully invested equity strategies with minimal cash, the manager avoids highly leveraged, high-beta, and unprofitable businesses, which highlights a cautious and risk-managed approach to capital allocation.
Capital Deployment
The fund maintains highly stable cash balances (mostly ~1.9% to 3.6% of portfolio assets) and engages in moderate net trading activity, adding selectively to nine positions and trimming four during the quarter in the Small Cap strategy.
Forward Guidance
The manager is actively managing portfolio weights, graduations, and market cap limits. High-quality growth names like Cloudflare are actively being added, and underperforming holdings with altered theses (like Neogen) are being harvested or exited.
Language Signal
The overall language is net-positive, heavily emphasizing 'stable compounders', 'high quality', and 'structural edge'. Negative language is largely restricted to describing macro risks and speculative, low-quality market conditions.
Perceived Risk
The manager details clear, structural risks around evolving US tariff policies and China trade tensions, which have materially impacted guidance for several of their holdings like Merit Medical and Energy Recovery.
Opportunity Density
Conestoga finds a healthy number of opportunities, especially in mid-to-small cap software and industrials, as revenue growth starts to accelerate following multiple years of contraction.
Time Horizon
The manager consistently references long-term growth expectations and multi-year holdings (e.g., FICO and AXON held since 2018 and 2019), exhibiting a patient, compounder-oriented investment horizon.
